Celldex Therapeutics, Inc. <CLDX.O>: Leerink Partners Raises Target Price to $88 From $70
CLDX•Related News
SPEEA Says Bargaining Unit Councils Are Recommending That Members Accept Boeing's Latest Offer
BA•
Advanced Flower Capital director Leonard M. Tannenbaum acquires $34,900 of common shares
AFCG•
4D Molecular Therapeutics Chief Legal Officer Scott Bizily disposes of USD 22,317.75 in common shares
FDMT•
TXNM Energy declares quarterly dividend of $0.42 per share
TXNM•
Snap files Form 3 as Chief Commercial Officer Ronan Harris reports 6,966,975 Class A shares owned
SNAP•